UC San Diego researchers and collaborators in Italy identified an inhibitor that may be effective against DYRK1A, an emerging target for Alzheimer’s disease. In the lab, the inhibitor reduced phosphate tags added to tau — a protein that accumulates in Alzheimer’s neurons — by enzymes called kinases, thus stabilizing cell structures. They say this kinase inhibitor is a promising prototype for new therapeutics that tackle tau hyperphosphorylation, which occurs in some neurodegenerative diseases.
- Advertisement -
Latest article
Take it from the rats: A junk food diet can cause long-term damage to...
A new USC-led study on rats that feasted on a high-fat, sugary diet raises the possibility that a junk food-filled diet in teens may...
Repurposing non-pharmacological interventions for Alzheimer’s disease through link prediction on biomedical literature
The complete workflow is depicted in Fig. 1. To investigate the association between NPIs and AD, we initially conducted preprocessing and integration of biomedical triples...
Degenerative Dementias and Their Medical Care in the Movies
Compared with other neurologic problems, few films have been dedicated to degenerative dementia. To our knowledge, this is the first systematic review about the...